Skip to main content
Paul Watkins, MD, Gastroenterology, Chapel Hill, NC

Paul B Watkins MD

Gastroenterology•Chapel Hill, NC

Howard Q Ferguson Distinguished Professor, Director, Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill

Join to View Full Profile

  • 101 Manning DrChapel Hill, NC 27599

  • Phone+1 919-226-3140

  • Fax+1 919-226-3150

Dr. Watkins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Watkins' Full ProfileAlready have an account?

Summary

  • I am a board certified gastroenterologist specializing in liver diseases, particularly drug-induced liver injury.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Gastroenterology, 1982 - 1985
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1979 - 1982
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1979

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1999 - 2026
  • MI State Medical License
    MI State Medical License 1986 - 2005
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Agilent Thought Leader Award 2015
  • Rawls Palmer Innovation in Medicine Award 2015
  • Elected Fellow of the AASLD American Association for the Study of Liver Diseases, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Review Post Screen Advancing Nonclinical Innovation and Safety in Pharmaceutical Testing  
    Michael N Liebman, Elizabeth J Baker, Paul B Watkins, ScienceDirect
  • A Rapid Method to Estimate Hepatocyte Loss Due to Drug‐Induced Liver Injury  
    Paul Watkins, MD, Clinical Pharmacology & Therapeutics
  • Can BSEP Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? ‐ an International Transporter Consortium Perspective  
    Paul Watkins, MD, Clinical Pharmacology & Therapeutics

Press Mentions

  • First Approved Cancer Treatment for TGCT Included DILIsym Simulations in FDA Review
    First Approved Cancer Treatment for TGCT Included DILIsym Simulations in FDA ReviewOctober 27th, 2020
  • FDA Review of Approved Drug, Ubrogepant, Included DILIsym Simulations
    FDA Review of Approved Drug, Ubrogepant, Included DILIsym SimulationsSeptember 2nd, 2020
  • U.S. FDA Renews Annual DILIsym Software Licenses
    U.S. FDA Renews Annual DILIsym Software LicensesMay 6th, 2020
  • Join now to see all

Grant Support

  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • Research Triangle Center of Excellence in Regulatory Science and InnovationUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
  • University of North Carolina Clinical Center for DILINUNIV OF NORTH CAROLINA CHAPEL HILL2003–2028
  • University of North Carolina Clinical Center for DILINUNIV OF NORTH CAROLINA CHAPEL HILL2003–2028
  • UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training ProgramUNIV OF NORTH CAROLINA CHAPEL HILL2011–2026
  • UNC Clinical Translation Science Award-T32 Program (TL1)National Center For Research Resources2008
  • UNC Clinical Translation Science Award-K12 Scholars Program (KL2)National Center For Research Resources2008
  • Toxicogenomics Of Acetaminophen Hepatotoxicity- Rechallenge ProtocolNational Center For Research Resources2008
  • Toxicogenomics Of Acetaminophen HepatotoxicityNational Center For Research Resources2008
  • Acetaminophen (Tylenol?) Induced Human Lymphocyte ToxicityNational Center For Research Resources2008
  • Effect Of Acetaminophen (TYLENOL) On Human LymphocytesNational Center For Research Resources2007–2008
  • Environmental Polymorphisms RegistryNational Center For Research Resources2006–2008
  • A Multicenter, Longitudinal Study Of Drug And CAM Induced Liver InjuryNational Center For Research Resources2005–2008
  • Gene Expression And AcetaminophenNational Center For Research Resources2007
  • Furanocoumarins And Drugs Effect On CYP3A4National Institute Of General Medical Sciences1999–2007
  • Toxicogenomics Of Acetaminophen ToxicityNational Center For Research Resources2005–2006
  • Drug Induced Liver Injury Network-Idiosyncratic Liver InjuryNational Center For Research Resources2005–2006
  • Role Of Cytochrome P450 3A5 Genotype Upon Fluconazole/MidazolamNational Center For Research Resources2004–2006
  • General Clinical Research Centers Annual MeetingNational Center For Research Resources2002–2006
  • Genetic Database For Genetic Polymorphisms Implicated In Drug MetabolismNational Center For Research Resources2005
  • Fc-Free Grapefruit Juice On The Oral Clearance Of Felodipine And CyclosporinNational Center For Research Resources2004–2005
  • Cytochrome P450 3A5 Genotype With Measures Of Blood Pressure And CardiovascularNational Center For Research Resources2004
  • Genetic Factors And Autoantibodies In Drug Induced DiseaseNational Center For Research Resources1998–2002
  • 13C Erythromycin Breath Test To Determine Drug DosagesNational Center For Research Resources1998–2002
  • Effect Of Grapefruit Juice &Seville Orange Juice On Felodipine DispositionNational Center For Research Resources1999–2000
  • P450 Activity And Intestinal Gene Expression Predicts Tacrolimus BioavailabilityNational Center For Research Resources1998–2000
  • Grapefruit Juice Component Responsible For Enhancing Felodipine BioavailabilityNational Center For Research Resources1998–2000
  • Cyclosporin A Bioavailability From Hepatic &Enteric P450 3A4 Catalytic ActivityNational Center For Research Resources1998–2000
  • Diet &Medications On Expression Of CYP3A4 &Cyp3a5 In Intestinal MucosaNational Center For Research Resources1996–2000
  • Furanocoumarins And Drugs Effect On CYP3A4National Institute Of General Medical Sciences1998
  • Predicting Cyclosporin A Bioavailability From Hepatic And Enteric P450 3A4National Center For Research Resources1997
  • Genetic Factors And Auto-Antibodies In Drug Induced DiseaseNational Center For Research Resources1997
  • Component Grapefruit Juice Which Enhances Bioavailability Of FelodipineNational Center For Research Resources1997
  • CYP3A4 And CYP3A5 In IntestineNational Institute Of General Medical Sciences1994–1997
  • Noninvasive Tests Of P450 IIIA Enzymes In ManNational Institute Of Environmental Health Sciences1996
  • Genetic Factors, And Autoantibodies, In Patients With Drug Induced DiseaseNational Center For Research Resources1996
  • Effect Of Oral Ketoconazole Therapy On Pharmokinetics Of Taxol--Pilot StudyNational Center For Research Resources1996
  • Component Grapefruit Juice Responsible For BioavailabilityNational Center For Research Resources1996
  • Regulation Of P-450 III Cytochromes In Liver &IntestineNational Institute Of General Medical Sciences1992–1993
  • Nonvasive Assays Of P450IIIA Enzymes In ManNational Institute Of Environmental Health Sciences1991
  • Environmental And Genetic Factors Regulating HlpNational Institute Of General Medical Sciences1986–1991

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Paul Watkins, Dr. Paul Watkins, MD, Dr. P Watkins, Dr. Paul B Watkins